Clinical Trial Update: Imatinib Mesylate in Treating Patients With Locally Advanced or Metastatic Dermatofibrosarcoma Protuberans or Giant Cell Fibroblastoma [Phase 2]

View source ↗

Summary

A Phase 2 study evaluating imatinib mesylate in patients with locally advanced or metastatic dermatofibrosarcoma protuberans or giant cell fibroblastoma has com…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Dermatofibrosarcoma Protuberans
• Giant Cell Fibroblastoma

Drugs mentioned

• Imatinib Mesylate (Gleevec) (Imatinib mesylate)

Snippet

Sponsor: European Organisation for Research and Treatment of Cancer - EORTC | Conditions: Sarcoma | Phase 2 | Status: COMPLETED